Quanterix (QTRX) Other financing activities (2018 - 2024)

Quanterix (QTRX) reported Other financing activities of $599000.0 for Q1 2024, up 8.71% on a YoY basis from $551000.0 in Q2 2023, and up 198.01% quarter-over-quarter from $201000.0 in Q4 2023.

Quanterix (QTRX) Other financing activities (2018 - 2024) Analysis & Trends

Quanterix has reported Other financing activities for 4 years, with the latest figure at $599000.0 in Q1 2024.

  • For the quarter ending Q1 2024, Other financing activities rose 8.71% year-over-year to $599000.0; the trailing twelve-month figure through Mar 2024 stood at $2.7 million (up 45.54% YoY), and the FY2023 full-year result was $2.7 million, up 16.49% from the prior year.
  • Other financing activities for Q1 2024 stood at $599000.0, up from $201000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.8 million in Q3 2023, with the low at $139000.0 in Q2 2023.
  • Historically, Other financing activities has averaged $577625.0 across 3 years, with a median of $479000.0 in 2022.
  • The largest YoY upside for Other financing activities was 342.26% in 2023 against a maximum downside of 71.81% in 2023.
  • Quanterix's Other financing activities stood at $713000.0 in 2022, then plunged by 71.81% to $201000.0 in 2023, then jumped by 198.01% to $599000.0 in 2024.
  • The last three Other financing activities figures came in at $599000.0 (Q1 2024), $201000.0 (Q4 2023), and $1.8 million (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Quanterix 146.10 Mn 46.84 Mn 15.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 599,000.00
Mar 31, 2024 599,000.00
Dec 31, 2023 201,000.00
Dec 31, 2023 201,000.00
Sep 30, 2023 1.80 Mn
Sep 30, 2023 1.80 Mn
Jun 30, 2023 139,000.00
Jun 30, 2023 139,000.00
Mar 31, 2023 551,000.00
Mar 31, 2023 551,000.00
Dec 31, 2022 713,000.00
Dec 31, 2022 713,000.00
Sep 30, 2022 407,000.00
Sep 30, 2022 407,000.00
Jun 30, 2022 211,000.00
Jun 30, 2022 211,000.00
Sep 30, 2018 303,000.00
Sep 30, 2018 303,000.00
Jun 30, 2018 297,000.00
Jun 30, 2018 297,000.00